Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: Results from a pilot study

Hepato-Gastroenterology

Volumn 48, Issue 37, 2001, Pages 208-211

  Furuse, J ^a   Maru, Y ^a   Yoshino, M ^a   Mera, K ^a   Sumi, H ^a   Tajiri, H ^a   Satake, M ^a   Onaya, H ^a   Ishikura, S ^a   Ogino, T ^a   Kawashima, M ^a   Ikeda, H ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

5 fluorouracil; Hepatic arterial infusion; Liver metastasis; Pancreatic carcinoma

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; LEUKOPENIA; LIVER METASTASIS; MALE; NAUSEA; PANCREAS CARCINOMA; PRIORITY JOURNAL; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PILOT PROJECTS; SURVIVAL RATE;

EID: 0035106482     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Pancreatic carcinoma
2. The role of chemotherapy in the treatment of adenocarcinoma of the pancreas
3. No standard treatment is available for advanced pancreatic cancer
4. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial
5. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
6. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma
7. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature
8. Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer
9. Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer
10. Adjuvant therapies in extended pancreatectomy for ductal adenocarcinoma of the pancreas
11. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
12. Phase II study of continuous venous infusion of 5-fluorouracil in advanced pancreatic cancer